✦ LIBER ✦

Comparative Effects of Different Doses of Ribavirin Plus Interferon-α2b for Therapy of Chronic Hepatitis C: Results of a Controlled, Randomized Trial

✍ Scribed by Herbert L. Bonkovsky; Denise Stefancyk; Kristina McNeal; Barbara F. Banner; Qin Liu; Geoffrey M. Zucker; Jonathan Israel; John Stagias; Joel Colker

Book ID: 110305322
Publisher: Springer US
Year: 2001
Tongue: English
Weight: 103 KB
Volume: 46
Category: Article
ISSN: 0163-2116
DOI: 10.1023/a:1011919906194

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pegylated α-interferon-2a plus ribavirin

Pegylated α-interferon-2a plus ribavirin compared with pegylated α-interferon-2b plus ribavirin for initial treatment of chronic hepatitis C virus: Prospective, non-randomized study

✍ Amparo Escudero; Felicidad Rodríguez; Miguel A Serra; Juan A Del Olmo; Francisco 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

Interferon-α plus ribavirin in chronic h

Interferon-α plus ribavirin in chronic hepatitis C resistant to previous interferon-α course: results of a randomized multicenter trial

✍ Pietro Andreone; Annagiulia Gramenzi; Carmela Cursaro; Giorgio Sbolli; Sirio Fio 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 726 KB

Randomized trial of peginterferon α-2a p

Randomized trial of peginterferon α-2a plus ribavirin versus peginterferon α-2b plus ribavirin for chronic hepatitis C in Japanese patients

✍ Shiho Miyase, Katsuki Haraoka, Yoshihiro Ouchida, Yuko Morishita, Shigetoshi Fuj 📂 Article 📅 2012 🏛 Springer Japan 🌐 English ⚖ 227 KB

Peginterferon alfa-2b plus ribavirin com

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

✍ Michael P Manns; John G McHutchison; Stuart C Gordon; Vinod K Rustgi; Mitchell S 📂 Article 📅 2001 🏛 The Lancet 🌐 English ⚖ 110 KB

High doses of recombinant α-interferon o

High doses of recombinant α-interferon or γ-interferon for chronic hepatitis C: A randomized, controlled trial

✍ Federico Sáez-royuela; Juan Carlos Porres; Alberto Moreno; Inmaculada Castillo; 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 438 KB

Chronic hepatitis C is often a progressive liver disease for which there is no satisfactory treatment. We studied the efficacy of recombinant a-interferon or y-interferon in the treatment of this disease in comparison with a control group. Thirty patients were randomly assigned to three groups. Ten

Interferon-α and zidovudine combination

Interferon-α and zidovudine combination therapy for chronic hepatitis B: Results of a randomized, placebo-controlled trial

✍ Harry L. A. Janssen; Luuk Berk; Rudolf A. Heijtink; Fiebo J. W. Ten Kate; Solko 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 630 KB

Interferon-a therapy leads to HBeAg seroconversion in only one third of patients with chronic hepatitis B. In an attempt to increase the seroconversion rate, we investigated the combination of interferon-a and zidovudine in a subset of patients with presumably low response rates for interferon-a mon